ZIEXTENZO

NDC 61314-866 · Sandoz Inc

Generic namepegfilgrastim-bmez

Dosage formINJECTION

RouteSUBCUTANEOUS

Active ingredient(s)PEGFILGRASTIM

Strength6 mg/.6mL

Pharmacologic classGranulocyte Colony-Stimulating Factor [CS], Increased Myeloid Cell Production [PE], Leukocyte Growth Factor [EPC]

Marketing categoryBLA

Packages

61314-866-02 — 1 BLISTER PACK in 1 CARTON (61314-866-02) / 1 SYRINGE in 1 BLISTER PACK / .6 mL in 1 SYRINGE

Billed under HCPCS

Q5120 — Injection, pegfilgrastim-bmez (ziextenzo), biosimilar, 0.5 mg Medicare Part B payment limit (ASP + 6%): $302.25

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0069-0324 — pegfilgrastim-apgf, 55513-099 — pegfilgrastim, 55513-190 — pegfilgrastim, 65219-371 — pegflilgrastim-fpgk, 69448-025 — pegfilgrastim-cbqv, 69448-026 — pegfilgrastim-cbqv, 69448-027 — pegfilgrastim-cbqv, 70114-101 — pegfilgrastim-cbqv, 70114-120 — pegfilgrastim-cbqv, 70114-130 — pegfilgrastim-cbqv, 70121-1627 — pegfilgrastim, 70748-273 — pegfilgrastim-unne, 72603-402 — pegflilgrastim-fpgk, 83257-005 — pegfilgrastim-jmdb

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q4 (October 2026 release). All data sources · How to read the labels

Current data releases:ICD-10-CM FY2027 · ICD-10-PCS FY2027 · HCPCS October 2026 · MS-DRG v44 · Medicare Code Editor v44.0 · NCCI PTP Q4 2026 · MUE Q4 2026 · NCD code lists 2026-01 · LCD export September 28, 2026 · All releases and sources